Literature DB >> 7308524

The significance of the Fc part of antispermatozoal antibodies for the shaking phenomenon in the sperm-cervical mucus contact test.

S Jager, J Kremer, J Kuiken, I Mulder.   

Abstract

Donor spermatozoa with good motility were pretreated with four sera containing high titers of sperm-agglutinating IgG, one serum without sperm-agglutinating activity, the IgG fractions from these five sera, F(ab)2 and Fragment antigen binding (Fab) fragments from these sera and from the IgG fractions, and one seminal plasma sample with a high titer of sperm-agglutinating IgA. With mixed antiglobulin reaction tests the percentage of motile pretreated spermatozoa sensitized with IgG Fab or IgG Fragment crystalline (Fc) parts was determined. Spermatozoa sensitized with intact antispermatozoal IgG showed a strong reduction in their capacity to penetrate cervical mucus. The reduction of the penetration capacity was determined by estimation of the percentage of motile spermatozoa rapidly shaking (S%) in the sperm-cervical mucus contact (SCMC) test. Removal of the Fc parts resulted in a decreased S%. Treatment of spermatozoa, on which Fab fragments were present, with intact antibodies to IgG Fab fragments, resulted in a recurrence of a high S%. A decrease of the S% was also found if Fab fragments from antibodies to IgG Fc fragments were added to spermatozoa sensitized with intact antispermatozoal IgG. Similarly, it was found that a decrease of the S% occurred when IgA sensitized spermatozoa were treated with Fab fragments from antibodies to human IgA. In the sperm penetration meter test the IgA sensitized spermatozoa treated with Fab fragments from anti-human IgA antibodies showed a better penetration than untreated IgA-sensitized spermatozoa.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308524     DOI: 10.1016/s0015-0282(16)45927-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Diffusion of macromolecules and virus-like particles in human cervical mucus.

Authors:  S S Olmsted; J L Padgett; A I Yudin; K J Whaley; T R Moench; R A Cone
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

2.  Production of heavy-chain class-switch variants of human monoclonal antibody by recombinant DNA technology.

Authors:  S Komori; N Yamasaki; M Shigeta; S Isojima; T Watanabe
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 3.  Diagnosis and treatment of immunologically infertile males with antisperm antibodies.

Authors:  Hiroaki Shibahara; Yasuko Shiraishi; Mitsuaki Suzuki
Journal:  Reprod Med Biol       Date:  2005-05-03

Review 4.  Micro- and macrorheology of mucus.

Authors:  Samuel K Lai; Ying-Ying Wang; Denis Wirtz; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2009-01-03       Impact factor: 15.470

Review 5.  Antisperm antibodies and conception.

Authors:  L W Chamley; G N Clarke
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

Review 6.  The biophysical principles underpinning muco-trapping functions of antibodies.

Authors:  Alison Schaefer; Samuel K Lai
Journal:  Hum Vaccin Immunother       Date:  2021-07-27       Impact factor: 4.526

7.  Differential binding of IgG and IgA to mucus of the female reproductive tract.

Authors:  Kelly M Fahrbach; Olga Malykhina; Daniel J Stieh; Thomas J Hope
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

8.  IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections.

Authors:  Y-Y Wang; A Kannan; K L Nunn; M A Murphy; D B Subramani; T Moench; R Cone; S K Lai
Journal:  Mucosal Immunol       Date:  2014-02-05       Impact factor: 7.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.